Table 2.

Organ involvement in hypereosinophilic syndrome


Organ system

Cumulative frequency from 3 studies, %*

Examples of organ-specific manifestations
Hematologic   100   Leukocytosis with eosinophilia; neutrophilia, basophilia, myeloid immaturity, immature and/or dysplastic eosinophils; anemia, thrombocytopenia or thrombocytosis, increased marrow blasts, myelofibrosis19,21  
Cardiovascular   58   Cardiomyopathy,28,29  constrictive pericarditis,30,31  endomyocarditis,32,33  mural thrombi,27,34  valvular dysfunction,27,35,36  endomyocardial fibrosis,37,38  myocardial infarction39  
Dermatologic   56   Angioedema,40  urticaria,40  papules/nodules,40  plaques,41  aquagenic pruritis,42  erythroderma,43  mucosal ulcers,44  vesicobullous lesions,45  microthrombi,46,47  vasculitis,48  Wells syndrome49  
Neurologic   54   Thromboembolism,50  peripheral neuropathy,50,51  encephalopathy,50,52  dementia,53,54  epilepsy,55  cerebellar disease,56  eosinophilic meningitis57  
Pulmonary   49   Pulmonary infiltrates,9,58  effusions,9,59  fibrosis, emboli,60  nodules/focal ground glass attenuation,61  acute respiratory distress syndrome (ARDS)62  
Splenic   43   Hypersplenism, infarct63  
Liver/gallbladder   30   Hepatomegaly,64  focal or diffuse hepatic lesions on imaging,64  chronic active hepatitis,65  hepatic necrosis,66  Budd-Chiari syndrome,67  sclerosing cholangitis,68  cholecystitis,69  cholestasis70  
Ocular   23   Microthrombi,71-73  choroidal infarcts,72  retinal arteritis,73  episcleritis,74  keratoconjunctivitis sicca,74  Adie syndrome (pupillotonia)75  
Gastrointestinal   23   Ascites,76  diarrhea,77  gastritis,78  colitis,69,78  pancreatitis77  
Musculoskeletal   N/A   Arthritis,79,80  effusions,80  bursitis,81  synovitis,82  Raynaud phenomena,83  digital necrosis,84  polymyositis/myopathy85,86  
Renal
 
N/A
 
Acute renal failure with Charcot-Leyden crystalluria,87  nephrotic syndrome,88  immunotactoid glomerulopathy,89  crescentic glomerulonephritis90 
 

Organ system

Cumulative frequency from 3 studies, %*

Examples of organ-specific manifestations
Hematologic   100   Leukocytosis with eosinophilia; neutrophilia, basophilia, myeloid immaturity, immature and/or dysplastic eosinophils; anemia, thrombocytopenia or thrombocytosis, increased marrow blasts, myelofibrosis19,21  
Cardiovascular   58   Cardiomyopathy,28,29  constrictive pericarditis,30,31  endomyocarditis,32,33  mural thrombi,27,34  valvular dysfunction,27,35,36  endomyocardial fibrosis,37,38  myocardial infarction39  
Dermatologic   56   Angioedema,40  urticaria,40  papules/nodules,40  plaques,41  aquagenic pruritis,42  erythroderma,43  mucosal ulcers,44  vesicobullous lesions,45  microthrombi,46,47  vasculitis,48  Wells syndrome49  
Neurologic   54   Thromboembolism,50  peripheral neuropathy,50,51  encephalopathy,50,52  dementia,53,54  epilepsy,55  cerebellar disease,56  eosinophilic meningitis57  
Pulmonary   49   Pulmonary infiltrates,9,58  effusions,9,59  fibrosis, emboli,60  nodules/focal ground glass attenuation,61  acute respiratory distress syndrome (ARDS)62  
Splenic   43   Hypersplenism, infarct63  
Liver/gallbladder   30   Hepatomegaly,64  focal or diffuse hepatic lesions on imaging,64  chronic active hepatitis,65  hepatic necrosis,66  Budd-Chiari syndrome,67  sclerosing cholangitis,68  cholecystitis,69  cholestasis70  
Ocular   23   Microthrombi,71-73  choroidal infarcts,72  retinal arteritis,73  episcleritis,74  keratoconjunctivitis sicca,74  Adie syndrome (pupillotonia)75  
Gastrointestinal   23   Ascites,76  diarrhea,77  gastritis,78  colitis,69,78  pancreatitis77  
Musculoskeletal   N/A   Arthritis,79,80  effusions,80  bursitis,81  synovitis,82  Raynaud phenomena,83  digital necrosis,84  polymyositis/myopathy85,86  
Renal
 
N/A
 
Acute renal failure with Charcot-Leyden crystalluria,87  nephrotic syndrome,88  immunotactoid glomerulopathy,89  crescentic glomerulonephritis90 
 

Modified from Weller and Bubley21  and from Brito-Babapulle17  with permission from Elsevier.

N/A indicates not available.

*

Data are taken from Fauci et al, Spry et al,19  and Lefebure et al.20 

or Create an Account

Close Modal
Close Modal